Amlodipine + HCTZ + Valsartan Tablets Manufacturer in India

Product Overview
Key Features
Therapeutic Uses
Dosage Form Advantages

Genliva Wellness LLP manufactures Amlodipine + HCTZ + Valsartan Tablets for hypertension management, cardiovascular protection, and blood pressure regulation in patients requiring triple combination antihypertensive therapy.

The formulation combines Amlodipine for blood vessel relaxation, Hydrochlorothiazide for fluid reduction through diuretic action, and Valsartan for angiotensin receptor blockade to support effective long-term blood pressure control and cardiovascular management.

The company supplies these medicines as an Antihypertensive Tablets Manufacturer in India, Cardiovascular Care Medicine Exporter, and Blood Pressure Control Medicine Supplier for pharmaceutical distributors, institutional healthcare providers, and international heart care markets.

Amlodipine + HCTZ + Valsartan Tablets are formulated for advanced hypertension management.

Triple combination antihypertensive formulation
Frequently utilized in blood pressure management
Supports cardiovascular and circulatory care
Combines calcium channel blocker and ARB therapy
Manufactured using quality pharmaceutical ingredients
Intended for long-term heart care management

This formulation is prescribed in cardiovascular management therapies.

Treatment of hypertension conditions
Management of high blood pressure
Administered in cardiovascular care protocols
Utilized in long-term antihypertensive therapies
Helps support blood pressure regulation
Frequently selected in heart care management

Amlodipine + HCTZ + Valsartan Tablets deliver combination cardiovascular therapy for hypertension care.

Valuable in blood pressure management
Frequently preferred in cardiovascular treatment
Triple-action antihypertensive therapy support
Useful in long-term heart care management
Convenient oral cardiovascular therapy option
Maintains reliable antihypertensive therapeutic performance